192 related articles for article (PubMed ID: 10477671)
1. Role of CYP2E1 in the pathogenesis of alcoholic liver disease: modifications by cAMP and ubiquitin-proteasome pathway.
Gouillon ZQ; Miyamoto K; Donohue TM; Wan YJ; French BA; Nagao Y; Fu P; Reitz RC; Hagbjork A; Yap C; Yuan QX; Ingelman-Sundberg M; French SW
Front Biosci; 1999 Sep; 4():A16-25. PubMed ID: 10477671
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of ethanol-induced liver disease in the intragastric feeding rat model by chlormethiazole.
Gouillon Z; Lucas D; Li J; Hagbjork AL; French BA; Fu P; Fang C; Ingelman-Sundberg M; Donohue TM; French SW
Proc Soc Exp Biol Med; 2000 Sep; 224(4):302-8. PubMed ID: 10964266
[TBL] [Abstract][Full Text] [Related]
3. Gadolinium chloride blocks alcohol-dependent liver toxicity in rats treated chronically with intragastric alcohol despite the induction of CYP2E1.
Koop DR; Klopfenstein B; Iimuro Y; Thurman RG
Mol Pharmacol; 1997 Jun; 51(6):944-50. PubMed ID: 9187260
[TBL] [Abstract][Full Text] [Related]
4. A voluntary oral ethanol-feeding rat model associated with necroinflammatory liver injury.
Tipoe GL; Liong EC; Casey CA; Donohue TM; Eagon PK; So H; Leung TM; Fogt F; Nanji AA
Alcohol Clin Exp Res; 2008 Apr; 32(4):669-82. PubMed ID: 18341647
[TBL] [Abstract][Full Text] [Related]
5. Modulation of experimental alcohol-induced liver disease by cytochrome P450 2E1 inhibitors.
Morimoto M; Hagbjörk AL; Wan YJ; Fu PC; Clot P; Albano E; Ingelman-Sundberg M; French SW
Hepatology; 1995 Jun; 21(6):1610-7. PubMed ID: 7768506
[TBL] [Abstract][Full Text] [Related]
6. Lipid peroxidation, CYP2E1 and arachidonic acid metabolism in alcoholic liver disease in rats.
French SW; Morimoto M; Reitz RC; Koop D; Klopfenstein B; Estes K; Clot P; Ingelman-Sundberg M; Albano E
J Nutr; 1997 May; 127(5 Suppl):907S-911S. PubMed ID: 9164261
[TBL] [Abstract][Full Text] [Related]
7. CYP-2E1 inhibitors partially ameliorate the changes in hepatic fatty acid composition induced in rats by chronic administration of ethanol and a high fat diet.
Morimoto M; Reitz RC; Morin RJ; Nguyen K; Ingelman-Sundberg M; French SW
J Nutr; 1995 Dec; 125(12):2953-64. PubMed ID: 7500173
[TBL] [Abstract][Full Text] [Related]
8. Dietary saturated fat reduces alcoholic hepatotoxicity in rats by altering fatty acid metabolism and membrane composition.
Ronis MJ; Korourian S; Zipperman M; Hakkak R; Badger TM
J Nutr; 2004 Apr; 134(4):904-12. PubMed ID: 15051845
[TBL] [Abstract][Full Text] [Related]
9. Production of a cytochrome P450 2E1 transgenic mouse and initial evaluation of alcoholic liver damage.
Morgan K; French SW; Morgan TR
Hepatology; 2002 Jul; 36(1):122-34. PubMed ID: 12085356
[TBL] [Abstract][Full Text] [Related]
10. Hepatocyte proliferation is the possible mechanism for the transient decrease in liver injury during steatosis stage of alcoholic liver disease.
Apte UM; McRee R; Ramaiah SK
Toxicol Pathol; 2004; 32(5):567-76. PubMed ID: 15603541
[TBL] [Abstract][Full Text] [Related]
11. Early alcoholic liver injury: formation of protein adducts with acetaldehyde and lipid peroxidation products, and expression of CYP2E1 and CYP3A.
Niemelä O; Parkkila S; Pasanen M; Iimuro Y; Bradford B; Thurman RG
Alcohol Clin Exp Res; 1998 Dec; 22(9):2118-24. PubMed ID: 9884160
[TBL] [Abstract][Full Text] [Related]
12. SUMOylation regulates cytochrome P450 2E1 expression and activity in alcoholic liver disease.
Tomasi ML; Ramani K; Ryoo M; Cossu C; Floris A; Murray BJ; Iglesias-Ara A; Spissu Y; Mavila N
FASEB J; 2018 Jun; 32(6):3278-3288. PubMed ID: 29401608
[TBL] [Abstract][Full Text] [Related]
13. Dilinoleoylphosphatidylcholine decreases ethanol-induced cytochrome P4502E1.
Aleynik MK; Lieber CS
Biochem Biophys Res Commun; 2001 Nov; 288(4):1047-51. PubMed ID: 11689017
[TBL] [Abstract][Full Text] [Related]
14. Induction mechanisms of cytochrome P450 2E1 in liver: interplay between ethanol treatment and starvation.
Hu Y; Ingelman-Sundberg M; Lindros KO
Biochem Pharmacol; 1995 Jul; 50(2):155-61. PubMed ID: 7632158
[TBL] [Abstract][Full Text] [Related]
15. Autophagy Protects against CYP2E1/Chronic Ethanol-Induced Hepatotoxicity.
Lu Y; Cederbaum AI
Biomolecules; 2015 Oct; 5(4):2659-74. PubMed ID: 26501338
[TBL] [Abstract][Full Text] [Related]
16. Fatty acid omega- and (omega-1)-hydroxylation in experimental alcoholic liver disease: relationship to different dietary fatty acids.
Amet Y; Adas F; Nanji AA
Alcohol Clin Exp Res; 1998 Oct; 22(7):1493-500. PubMed ID: 9802534
[TBL] [Abstract][Full Text] [Related]
17. Proteasome inhibitor up regulates liver antioxidative enzymes in rat model of alcoholic liver disease.
Bardag-Gorce F; Oliva J; Lin A; Li J; French BA; French SW
Exp Mol Pathol; 2011 Feb; 90(1):123-30. PubMed ID: 21036165
[TBL] [Abstract][Full Text] [Related]
18. Mallory body formation by ethanol feeding in drug-primed mice.
Zhang-Gouillon ZQ; Yuan QX; Hu B; Marceau N; French BA; Gaal K; Nagao Y; Wan YJ; French SW
Hepatology; 1998 Jan; 27(1):116-22. PubMed ID: 9425926
[TBL] [Abstract][Full Text] [Related]
19. Zonated expression of cytokines in rat liver: effect of chronic ethanol and the cytochrome P450 2E1 inhibitor, chlormethiazole.
Fang C; Lindros KO; Badger TM; Ronis MJ; Ingelman-Sundberg M
Hepatology; 1998 May; 27(5):1304-10. PubMed ID: 9581684
[TBL] [Abstract][Full Text] [Related]
20. Alterations in nuclear ploidy and cell phase distribution of rat liver cells in experimental alcoholic liver disease: relationship to antioxidant enzyme gene expression.
Fogt F; Nanji AA
Toxicol Appl Pharmacol; 1996 Jan; 136(1):87-93. PubMed ID: 8560485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
